You cannot select more than 25 topics
Topics must start with a letter or number, can include dashes ('-') and can be up to 35 characters long.
13 lines
679 B
Markdown
13 lines
679 B
Markdown
alias:: [[FDC]], [[coformulación]], [[fixed-dose coformulation]], [[fixed-dose combination]]
|
|
organization:: [[Liconsa]]
|
|
project:: [[STOP2030]]
|
|
lead-by:: [[Alejandro Krolewiecki]]
|
|
summary:: A combination at fixed doses of ivermectin and albendazole (9mg/400mg & 18mg/400mg) aimed at treating STH, but likely of use for scabies and LF. It has superior efficacy against ALB monotherapy against *T. trichiura* and *S. stercoralis*
|
|
status:: Sent for evaluation by EMA (art. 58) and Ghana FDA. Phase IV clinical trial in preparation
|
|
|
|
- [[FDC/Pharmacokinetics]]
|
|
- ## Prequalification at WHO
|
|
- Ale, Alan, Julie and Carla are in touch with Jonathan and
|
|
- ## Essential Medicines List
|
|
-
|
|
- |